Biotech Archives - Page 140 of 795

5 minute read

CytomX Therapeutics Outlines 2024 Company Priorities And Milestones

January 4, 9:15 AM

- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data anticipated in the 2nd half of 2024 - - IND application filed for conditionally activated EpCAM-directed ADC (CX-2051) with Phase 1

CTMX

3 minute read

Alimera Completes Recruitment For The Synchronicity Study

By Benzinga Newsdesk

January 4, 9:15 AM

Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer,

ALIM

2 minute read

Prophase Poised To Ramp Up Growth At Pharmaloz And Nebula Genomics In 2024; Company Announces The Hiring Of Long-Time Industry Veteran Jed Latkin As COO To Help Build And Manage This Growth

By Benzinga Newsdesk

January 4, 9:14 AM

Company also plans to commercialize its BE-Smart Esophageal Cancer Test in 2024Company announces the hiring of long-time industry veteran Jed Latkin as COO to help build and manage this growthGarden City, NY, Jan. 04,

PRPH

3 minute read

Cocrystal Pharma Provides An Update On The Clinical Development Of Its Novel, Broad-Spectrum Antiviral Investigational Candidates

By Benzinga Newsdesk

January 4, 9:13 AM

Cocrystal Pharma, Inc. (NASDAQ:COCP) ("Cocrystal" or the "Company") provides an update on the clinical development of its oral first-in-class pan-norovirus and pan-coronavirus dual protease inhibitor CDI-988 and its oral

COCP

2 minute read

Third Harmonic Bio Appoints Christopher Murphy As Chief Financial And Business Officer And Provides Business Update

By Benzinga Newsdesk

January 4, 9:06 AM

Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate strategy IND-enabling toxicology studies of THB335 nearing completion; Pre-IND interaction

THRD

1 minute read

Volition Issues Business Review 2023, Outlining Its Key Highlights From The Past Year

By Benzinga Newsdesk

January 4, 9:05 AM

VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, has issued a Business Review of 2023, outlining its key highlights from the past year.Volition's major achievements in 2023

VNRX

3 minute read

Ultragenyx Receives Positive Recommendation From NICE In The U.K. For Evkeeza For Adolescents And Adults Aged 12 Years And Older With Homozygous Familial Hypercholesterolemia

By Benzinga Newsdesk

January 4, 9:04 AM

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) today announced that the National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Evkeeza® (evinacumab) to NHS England.

RARE

2 minute read

Portage Biotech Reports Business And Strategic Update; Prioritize The Adenosine Clinical Candidates; iNKT Clinical Development Paused To Focus Resources; Company Will Evaluate Range Of Strategic Options

By Benzinga Newsdesk

January 4, 9:04 AM

Prioritize the adenosine clinical candidatesiNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc.

PRTG

7 minute read

Poseida Therapeutics Highlights Recent Progress, Strategic Priorities And Anticipated 2024 Key Milestones

By Benzinga Newsdesk

January 4, 9:03 AM

Reported positive early clinical data for allogeneic myeloma cell therapy P-BCMA-ALLO1 at ASH 2023 supporting potential of TSCM-rich allogeneic CAR-T to offer a differentiated and compelling efficacy, safety, and

PSTX

3 minute read

Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-Of-Concept Device That Has Transformative Potential For Women’s Health As Well As In Treating A Broad Range Of Diseases

By Benzinga Newsdesk

January 4, 9:02 AM

Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced that it has achieved technological proof of concept for DARE-LARC1 and the underlying innovative drug delivery platform

DARE